TCTR20220131004已完成不适用
Treatments and outcomes of endometrial cancers in Srinagarind Hospital
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 277
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 28 Years 至 86 Years（—）
- 性别
- Female
入选标准
- •Women who were diagnosed endometrial cancers and received surgeries in Srinagarind Hospital during 2016 - 2020
排除标准
- •Incomplete data
- •Benign diseases
- •Not done surgeries
- •Surgeries in other years
研究者
相似试验
招募中
不适用
Surgery or Medication for women with Endometrioma.endometriomaendometriosiscyst1004682810029903EndometriosisNL-OMON56253Maxima Medisch Centrum200
招募中
不适用
Operatieve of medicamenteuze behandeling van vrouwen met een endometrioom.NL-OMON22624Maxima Medical Center.184
进行中（未招募）
不适用
CONSERVATIVE MANAGEMENT OF ENDOMETRIAL CANCER AND ATYPICAL HYPERPLASIA - NDMedDRA version: 9.1Level: LLTClassification code 10007063EUCTR2010-018581-23-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE
招募中
1 期
Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials – p53abn - REDRandomized phase III trial testing maintenance olaparib versus observation after adjuvant chemoradiation for p53abn endometrial cancerPatients with a histological diagnosis of p53abn HREC, treated with curative intent, after surgery (hysterectomy and bilateral salpingooophorectomy, with or without lymphadenectomy or sentinel node biopsy), without signs of residual disease or distant metastasesCTIS2023-503886-44-00Institut Gustave Roussy150
尚未招募
3 期
Study of additional treatment after surgery in endometrial cancerCTRI/2024/08/072343eiden University Medical Center